CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Reinstatement to Official Quotation, page-22

  1. takizawa2
    11,996 Posts.
    lightbulb Created with Sketch. 1315
    clock Created with Sketch.
    02/12/19
    15:38
    Post #: 41750872


    Creso Pharma is looking to increase revenue from nutraceuticals and animal health products as part of its renewed strategy. The ASX cannabis group expects to generate more than $3.6 million in revenue in CY 2019 from the segment.

    Cost management was highlighted as a priority as Creso Pharma looks to reduce its monthly cash burn.
    CPH Price at posting: 14.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MGU Collaboration in a green (steel) future the focus for Magnum and Saudi partners
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
NEWS Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NXG Cost blow-out for Rook I uranium project sees share plummet for NexGen
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.